UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027470
Receipt number R000031456
Scientific Title Prospectively Assigned Database for Lymphedema
Date of disclosure of the study information 2017/07/03
Last modified on 2023/11/27 14:14:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospectively Assigned Database for Lymphedema

Acronym

Lymphedema Database (LED)

Scientific Title

Prospectively Assigned Database for Lymphedema

Scientific Title:Acronym

Lymphedema Database (LED)

Region

Japan


Condition

Condition

Lymphedema

Classification by specialty

Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to obtain the patients' clinical information prospectively and develop a database of lymphedema management, which can be comprehensively analyzed afterward.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

This study analyzes changes in subjective symptoms or objective findings.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

This study includes all the patients who are diagnosed with lymphedema at Center Hospital of the National Center for Global Health and Medicine in Japan.

Key exclusion criteria

Subjects who refuse to be registered

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Takumi
Middle name
Last name YAMAMOTO

Organization

The National Center for Global Health and Medicine

Division name

Plastic and Reconstructive Surgery

Zip code

162-8655

Address

1-21-1 Toyama Shinjuku-ku, Tokyo, 162-8655, JAPAN

TEL

+81-3-3202-7181

Email

tayamamoto@hosp.ncgm.go.jp


Public contact

Name of contact person

1st name Takumi
Middle name
Last name Yamamoto

Organization

The National Center for Global Health and Medicine

Division name

Plastic and Reconstructive Surgery

Zip code

165-0035

Address

1-21-1 Toyama Shinjuku-ku, Tokyo, 162-8655, JAPAN

TEL

+81-3-3202-7181

Homepage URL


Email

tyamamoto-tky@umin.ac.jp


Sponsor or person

Institute

The National Center for Global Health and Medicine

Institute

Department

Personal name



Funding Source

Organization

Not Applicable

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Center for Global Health and Medicine

Address

1-21-1 Toyama, Shinjuku-ku, Tokyo, Japan

Tel

+81-3-3202-7181

Email

rinrijm@hosp.ncgm.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立国際医療研究センター(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description


Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 04 Month 26 Day

Date of IRB

2017 Year 09 Month 08 Day

Anticipated trial start date

2017 Year 07 Month 03 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

In this study, subjective symptoms and objective findings are observed.


Management information

Registered date

2017 Year 05 Month 23 Day

Last modified on

2023 Year 11 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031456


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name